Close Menu
healthylife7.comhealthylife7.com

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Why too many women are prescribed antibiotics for UTIs they don’t have

    August 31, 2026

    New Phase 3b data on Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesity

    August 31, 2026

    Canadian employee well-being continues to decline as employers struggle to measure and improve outcomes

    August 31, 2026
    Facebook X (Twitter) Instagram
    Trending
    • Why too many women are prescribed antibiotics for UTIs they don’t have
    • New Phase 3b data on Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesity
    • Canadian employee well-being continues to decline as employers struggle to measure and improve outcomes
    • Psychology says people who save screenshots they never look at may be collecting a sense of future security
    • Ozempic adds another layer to the shame game
    • MRF-D Marines kick off multinational exercise Super Garuda Shield 26 in Indonesia
    • Global Markets for Fermentation Ingredients to Reach $53.4 Billion by 2031, Driven by Rising Demand for Animal Nutrition Ingredients
    • Home health, hospice deal-making on track to soar in 2027, report predicts
    Facebook X (Twitter) Instagram
    healthylife7.comhealthylife7.com
    • Home
    • Fitness
    • Health
    • Nutrition
    • Lifestyle
    • Conditions
    • Mental Health
    • Weight Loss
    • Wellness Tips
    Monday, August 31
    healthylife7.comhealthylife7.com
    Home»Conditions»Global Markets and Technologies for Electronic Health Records to Reach $52.2 Billion by 2030, Driven by Rising Chronic Disease Burden and Digital Health Adoption
    Conditions

    Global Markets and Technologies for Electronic Health Records to Reach $52.2 Billion by 2030, Driven by Rising Chronic Disease Burden and Digital Health Adoption

    healthylife7By healthylife7August 31, 2026No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
    Global Markets and Technologies for Electronic Health Records to Reach $52.2 Billion by 2030, Driven by Rising Chronic Disease Burden and Digital Health Adoption
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    This is a paid press release. Contact the press release distributor directly with any inquiries.

    Global Markets and Technologies for Electronic Health Records to Reach $52.2 Billion by 2030, Driven by Rising Chronic Disease Burden and Digital Health Adoption

    BCC Research LLC
    Mon, August 31, 2026 at 4:03 PM GMT+5:30
    4 min read

    BCC Research LLC

    “The global EHR market is projected to grow from $36.5 billion in 2025 to $52.2 billion by 2030 at a 7.4% CAGR as healthcare providers accelerate cloud deployment, interoperability and AI-enabled clinical workflows.”

    Boston, Aug. 31, 2026 (GLOBE NEWSWIRE) — The global market for electronic health records (EHR) is projected to expand from $34.2 billion in 2023 to $52.2 billion by 2030, at a compound annual growth rate (CAGR) of 7.4% during 2025–2030, according to the BCC Research report Global Markets and Technologies for Electronic Health Records (HLC205B). The analysis underscores a structural shift in healthcare delivery, as providers worldwide accelerate the digitization of patient data management to meet rising clinical, regulatory, and operational demands.

    • The global EHR market is forecast to reach $52.2 billion by 2030, advancing at a 7.4% CAGR from 2025 to 2030, underpinned by the escalating prevalence of chronic diseases—including diabetes, cardiovascular conditions, cancer, and neurological disorders—that require coordinated, data-intensive care management across specialties.• North America is the dominant regional market, accounting for 43.5% of global revenue, reflecting mature healthcare IT infrastructure, established regulatory frameworks such as HIPAA, and high levels of hospital system digitization across the United States and Canada.• Government mandates and national digital health programs are accelerating EHR adoption globally, with regulatory requirements compelling previously paper-based facilities to transition to electronic systems and public funding driving healthcare IT modernization across both developed and emerging economies.• Cloud-based SaaS deployment is reshaping the competitive landscape, lowering the barrier to entry for small and mid-sized practices by eliminating large upfront capital requirements, while enabling real-time remote access, continuous software updates, and improved interoperability across care settings.• Artificial intelligence, natural language processing (NLP), and FHIR-based interoperability standards are emerging as the next frontier of EHR innovation, enabling automated clinical documentation, predictive analytics, and seamless health information exchange across provider networks.• Key market participants include Epic Systems Corp., Oracle, Medical Information Technology Inc. (MEDITECH), Veradigm LLC, TruBridge, eClinicalWorks, Netsmart Technologies Inc., Athenahealth, CompuGroup Medical, AdvancedMD Inc., NXGN Management LLC., CureMD Healthcare, Greenway Health LLC, McKesson Corp., and Medsphere Systems Corp.

    Electronic global health markets Technologies
    healthylife7
    • Website

    Related Posts

    Why too many women are prescribed antibiotics for UTIs they don’t have

    August 31, 2026

    Global Markets for Fermentation Ingredients to Reach $53.4 Billion by 2031, Driven by Rising Demand for Animal Nutrition Ingredients

    August 31, 2026

    Home health, hospice deal-making on track to soar in 2027, report predicts

    August 31, 2026
    Leave A Reply Cancel Reply

    Health
    Conditions

    Why too many women are prescribed antibiotics for UTIs they don’t have

    By healthylife7August 31, 20260

    A recent study found that many women treated for recurrent UTIs didn’t have UTIs at all. Instead, their symptoms were caused by hormonally driven inflammation and pelvic floor dysfunction. BSIP/Universal Images Group/hide caption

    New Phase 3b data on Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesity

    August 31, 2026

    Canadian employee well-being continues to decline as employers struggle to measure and improve outcomes

    August 31, 2026

    Psychology says people who save screenshots they never look at may be collecting a sense of future security

    August 31, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Fitness

    Opinion: The FDA must put biotech at its center or continue to cede early research to China

    July 6, 2026

    Inside Elevance’s digital chronic disease management strategy

    July 6, 2026

    Best, Worst States For Well

    July 6, 2026

    What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

    July 6, 2026

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us

    Welcome to HealthyLife7.com, your trusted source for reliable health, wellness, fitness, and lifestyle information. Our mission is to help people make informed decisions about their health by providing clear, practical, and easy-to-understand content.

    At HealthyLife7.com, we believe that good health starts with the right knowledge. Whether you're looking for healthy eating tips, fitness advice, mental wellness strategies, weight management guidance, or information about common health conditions, our goal is to deliver valuable content that supports a healthier lifestyle.

    Fitness

    Why too many women are prescribed antibiotics for UTIs they don’t have

    August 31, 2026

    New Phase 3b data on Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesity

    August 31, 2026

    Canadian employee well-being continues to decline as employers struggle to measure and improve outcomes

    August 31, 2026
    Health

    Opinion: The FDA must put biotech at its center or continue to cede early research to China

    July 6, 2026

    Inside Elevance’s digital chronic disease management strategy

    July 6, 2026

    Best, Worst States For Well

    July 6, 2026
    Facebook X (Twitter) Instagram Pinterest
    • About Us
    • Contact us
    • Disclaimer
    • Privacy Policy
    • Terms and Conditions
    © 2026 healthylife7.com. Designed by Pro.

    Type above and press Enter to search. Press Esc to cancel.